Wells Fargo Reports Second Quarter 2024 Financial Results | Business
SAN FRANCISCO--(BUSINESS WIRE)--Jul 12, 2024--Wells Fargo & Company (NYSE: WFC) has released its second quarter 2024 financial results. The financial...
Reports
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
- Received U.S. Food and Drug Administration ("FDA") Breakthrough Therapy Designation ("BTD") for CYB003, its proprietary deuterated psilocybin analog in...
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
CRISPR Therapeutics AG-More than 25 authorized treatment centers (ATCs) activated globally for CASGEVY™ and multiple patients have already had cells...
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
iTeos Therapeutics Inc.- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of...
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Corvus Pharmaceuticals, Inc.Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End...
